Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Pergolide Mesylate Patent Expiration

Pergolide Mesylate was first introduced by Valeant Pharmaceuticals International in its drug Permax on Dec 30, 1988. 3 different companies have introduced drugs containing Pergolide Mesylate.


About Veterinary Pergolide Mesylate

Pergolide Mesylate is used in a drug marketed by 1 company: Boehringer Lngelheim Animal Health Usa Inc.

Other drugs containing Pergolide Mesylate are: Prascend .

Pergolide Mesylate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Pergolide Mesylate Generic API Manufacturers

Several generic applications have been filed for Pergolide Mesylate. The first generic version for Pergolide Mesylate was by Strides Pharma Global Pte Ltd and was approved on Nov 27, 2002. And the latest generic version is by Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa and was approved on Sep 4, 2003.

Given below is the list of companies who have filed for Pergolide Mesylate generic, along with the locations of their manufacturing plants worldwide.